Elf score liver calculator. The ELF Specification Sheet The ADVIA Centaur® systems’ Enhanced Liver Fibrosis (ELFTM) test is an in vitro diagnostic multivariate index assay intended to provide a single ELF score by combining in an algorithm the quantitative measurements of hyaluronic acid (HA), amino-terminal propeptide of type III procollagen (PIIINP), and tissue inhibitor of metalloproteinase 1 (TIMP-1) in human serum using May 28, 2024 · A decade has passed since non-invasive markers of liver fibrosis emerged, ranging from simple scores like APRI, FIB-4, NAFLD Fibrosis Score to more intricate tools such as the ELF Test, Fibrometer Aug 1, 2013 · The Enhanced Liver Fibrosis (ELF) score is an ECM marker set consisting of tissue inhibitor of metalloproteinases 1 (TIMP-1), amino-terminal propeptide of type III procollagen (PIIINP) and hyaluronic acid (HA) showing good correlations with fibrosis stages in chronic liver disease. 29, testing is reflexed to NASH FibroSure® Plus at an additional cost. 5 Low risk for advanced liver fibrosis. 5 days ago · Laboratory Workup for Biliary Colic with Hepatic Steatosis Order a comprehensive metabolic panel including liver enzymes (ALT, AST), complete metabolic profile, lipid panel, and calculate FIB-4 score as your initial laboratory assessment, followed by risk-stratified noninvasive fibrosis testing based on metabolic risk factors. The ELF Score can help identify patients with advanced fibrosis (F3 or F4) at risk of progressing to cirrhosis and liver-related events (LREs). Treat metabolic risk factors and if there is ongoing risk suggest repeating test in 3 years. The Enhanced Liver Fibrosis (ELF) Test is a noninvasive blood test that quantifies three analytes which directly contribute to liver fibrosis. 7–10 ELF is included as a NAFLD Fibrosis Score Calculator Estimate the risk of liver fibrosis based on clinical and laboratory data The ELF test is a simple blood test to assess Liver Fibrosis. If you are at risk of liver disease a FIB-4 or ELF test can help find out how much scarring is in your liver and what should happen next. 51, then advanced liver fibrosis is unlikely. 1 The Fibrosis-4 (FIB-4) Index for Liver Fibrosis is a non-invasive scoring system based on several laboratory tests that help to estimate the amount of scarring in the liver. Jun 18, 2024 · Calculators The following calculators have been collected here for general informational purposes. ELF ≥9. If your patient is morbidly obese, consider using a fibrosis score that does not incorporate BMI, such as FIB4. The liver is a complex organ, and a human even more so, and therefore we do not recommend making clinical decisions on the basis of these scores alone. Nov 11, 2025 · Ask any follow up question and get world-class guideline-backed answers instantly. We investigated the impact of adding the Enhanced Liver Fibrosis (ELF) score as a second-line test (subsequent to an indeterminate or high Fibrosis-4 index [FIB-4] and/or non-alcoholic fatty liver disease fibrosis score) to guide referral and prognostication in our multi-aetiology Mayo Clinic The Alcoholic Liver Disease/Nonalcoholic Fatty Liver Disease Index (ANI) calculator is a novel scoring system to distinguish alcoholic liver disease (ALD) from nonalcoholic fatty liver disease (NAFLD), for use by medical professionals. Progressive fibrosis is a major cause of morbidity and mortality in chronic liver disease. Background and aims: The enhanced liver fibrosis (ELF) score is a blood test that combines three markers linked to liver fibrosis. You can read more about the different names and what they mean below. The ELF Score Liver Calculator generally shows the highest accuracy for advanced fibrosis (around 90-94%), while the FIB-4 index offers excellent balance of accuracy and accessibility. The ELF test is recommended in the National Institute for Health and Care Excellence guidelines on the management of non-alcoholic fatty liver disease (NAFLD). 751 × In (amino-terminal propeptide of type III procollagen [PIIINP]) + 0. k. The ELF score can predict moderate fibrosis and cirrhosis. Recommend referral to Metabolic Hepatology Clinic. Aug 1, 2018 · The Enhanced Liver Fibrosis score has been recognized as a non-invasive test for liver fibrosis. Fibrosis-4 (FIB-4) Calculator Share The Fibrosis-4 score helps to estimate the amount of scarring in the liver. The enhanced liver fibrosis (ELF) test is a blood test that gives a score to reflect the severity of liver fibrosis. According to recommendations for blood testing and referral developed by AACE and cosponsored by AASLD, patients in the high-risk groups with an indeterminate or high FIB-4 index should be considered for further testing with the ELF score. Complications include progression to cirrhosis, end stage liver disease and hepatocellular carcinoma. a. The Enhanced Liver Fibrosis score (ELF score) Liver fibrosis can result from a number of pathological processes, the most common being chronic hepatitis B & C, alcohol abuse, and non-alcohol-related steatohepatitis (NASH). In contrast, indirect-biomarker panels merely reflect a mixture of biochemical abnormalities found in chronic liver disease that are not specific to NASH or fibrosis. The ELF Score is the first noninvasive biomarker blood test for prognostic risk assessment in advanced MASH. ELF measurements have proven valuable for assessing the likelihood of disease progression to cirrhosis and liver-related clinical events in patients with advanced fibrosis (F3 or F4) due to MASH. Jun 28, 2021 · The Enhanced Liver Fibrosis (ELF) test is a non-invasive test that combines measurements of three markers of hepatic extracellular matrix—procollagen type III N-terminal peptide, tissue inhibitor of metalloproteinase-1 and hyaluronic acid—to generate a unitless numerical score [11]. Use the interactive slide rule to see how the ELF score can indicate the state of liver fibrosis. Methods: This is a prospective study that We would like to show you a description here but the site won’t allow us. The test has the potential to identify people at high risk of advanced liver fibrosis earlier than the current standard of care. In this study, we have therefore defined the reference ranges of the ELF score and reevaluated the cut-off values, which have been suggested for the detection of liver fibrosis and cirrhosis. Each ELF Test biomarker composing the ELF score is: MASLD, NAFLD and fatty liver disease MASLD, NAFLD and fatty liver disease are different names for the same condition. The ELF The Enhanced Liver Fibrosis (ELF) score, originally derived and validated in patients with chronic liver disease, is an algorithm combining 3 serum markers, known as procollagen type III amino terminal propeptide (PIIINP), tissue inhibitor of metalloproteinases 1 (TIMP-1), and hyaluronic acid (HA). The ELF score is not for use in the diagnosis of NASH, the staging of fibrosis, the serial monitoring of disease progression, or the monitoring of effects of therapeutic products. Enhanced Liver Fibrosis (ELFTM) Test Understanding a person’s risk of progression to end-stage liver disease can lead to better patient management and significantly improved outcomes. We investigated the impact of adding the Enhanced Liver Fibrosis (ELF) score as a second-line test (subsequent to an indeterminate or The ELF Score is recommended by AACE guidelines,6 as its measurements have proven valuable for identifying patients with advanced fibrosis (F3 or F4) at risk of progressing to cirrhosis and liver-related events. Consider referral to hepatologist or liver transplant center for patients with elevated MELD score. 3 - 2. Estimates amount of scarring in the liver based on several laboratory tests. . It will appear in the oval on the far right (highlighted in yellow). 851 × In (hyaluronic acid [HA]) + 0. 8: Liver referral, ensure NILS and liver ultrasound performed. The ELF Test, in conjunction with other laboratory and clinical findings, can be used to assess the risk of progression to cirrhosis and LREs in patients with chronic liver disease. The ELF test has been validated in all common chronic liver diseases The ELF test also provides valuable prognostic information at least as accurate as liver biopsy. In community pathways for detection of liver disease the most common reason for referral is fibrosis assessment. FIB-4 index is calculated first; if FIB-4 index value is between 0 and 1. 8) in identifying severe fibrosis for This fibrosis 4 (FIB4) score calculator reveals whether there is significant liver fibrosis of different stages associated to cirrhosis using patient age, AST & ALT. It is used with other laboratory findings and clinical tests in patients with advanced fibrosis due to NASH to assess the likelihood of their disease progressing to cirrhosis. Only assayed if abnormal FIB-4 result. To replace liver biopsy for disease staging, multiple serum markers are under evaluation with multiparametric panels yielding the most promising results. However, influence factors such as gender and age need to be taken into account. As per the locally agreed primary care pathway, the ELF test should be considered for the assessment of liver fibrosis in adult patients with NAFLD. Nov 7, 2025 · Learn how the FIB-4 Index uses AST, ALT, platelets, and age to estimate liver fibrosis risk—plus how to self-calculate without charges. This NAFLD fibrosis score calculator stratifies the degree of fibrosis to the liver in nonalcoholic fatty liver disease patients by assigning a specific stage. The ELF Jul 18, 2025 · The ELF score represents an important advance in non-invasive assessment of liver fibrosis that can help identify patients at risk for disease progression and adverse outcomes. • To assess the risk of NAFLD with liver fibrosis, use liver fibrosis prediction calculations. To date, a liver biopsy is still considered the gold standard for staging fibrosis. Please feel free to explore these resources and the supporting published evidence. The Enhanced Liver Fibrosis (ELF) Score is a noninvasive test that indicates whether a patient with NASH and advanced fibrosis has a higher or lower risk of disease progression to cirrhosis (for those with F3 fibrosis) or other liver-related clinical events (for those with F3 or F4 fibrosis) within 1 to 4 years. Please fill out required fields. The Enhanced Liver Fibrosis (ELF) score is an ECM marker set consisting of tissue inhibitor of metalloproteinases 1 (TIMP-1), amino-terminal propeptide of type III procollagen (PIIINP) and hyaluronic acid (HA) showing good correlations with fibrosis stages in chronic liver disease. Special precautions & notes: Only available to primary care. The aim of this study was to investigate the diagnostic accuracy of the commercial enhanced liver fibrosis (ELF) test manufacturer's cutoff value (≥9. • Consider persons belonging to the “high risk” group who have an indeterminate or high FIB-4 score for further workup with an ELF test. Clinical Significance Enhanced Liver Fibrosis (ELF) Score - The Enhanced Liver Fibrosis (ELF) score predicts progression to cirrhosis and liver-related events in patients with advanced fibrosis due to NASH. Er ist zur Beurteilung der Leber- fibrose und des Fibrosegrades bei NAFLD, Alkoholischer Lebererkrankung, Hepatitis C und in gemischten Kohor-ten geeignet. Nov 17, 2022 · ELF score defines a three-marker fibrosis test (TIMP-1, PIIINP, HA) for assessing advanced fibrosis in NAFLD, guiding referrals and monitoring intervals. What tool/s can you use for secondary risk assessment of patients with fatty liver disease? VCTE or Enhanced Liver Fibrosis (ELF) are the preferred tools for secondary risk assessment of patients with MASLD in the primary care or endocrinology practice settings. Jun 21, 2024 · Background and aims: The enhanced liver fibrosis (ELF) score is a blood test that combines three markers linked to liver fibrosis. 7–10 ELF is included as a Nov 17, 2022 · ELF score defines a three-marker fibrosis test (TIMP-1, PIIINP, HA) for assessing advanced fibrosis in NAFLD, guiding referrals and monitoring intervals. Check your ELF Score Liver Calculator results to assess liver fibrosis, track liver health, and understand your risk with accurate scoring. However, reference intervals, biological variation an… Apr 14, 2016 · Enhanced Liver Fibrosis (ELF) test is a novel blood test that measures levels of three direct markers [Hyaluronic Acid (HA), Amino-terminal Propeptide of Type III collagen (PIIINP) and Tissue Inhibitor of Matrix Metalloproteinase 1 (TIMP-1)] of fibrosis and utilizes an algorithm to generate a numeric score. The test helps identify significant fibrosis or cirrhosis, assess disease progression, and guide treatment decisions. 67 (Indeterminate) ELF <9. Use The Enhanced Liver Fibrosis (ELF™) blood test is a simple, accurate, non-invasive test that provides a simple, unitless numeric score that is generated via an algorithm for use in advanced liver fibrosis. Current recommendations state that use of vibration controlled transient elastography, which is utilized in FibroScan, is the best validated tool to identify advanced liver disease and predict liver-related outcomes. The utility of the ELF score has been demonstrated primarily in Western countries, but whether it is useful in areas with a high number of elderly people suffering from chronic liver disease has yet to be determined. Reference range: >9. The video explains the significance and ease of the ELF test for managing your Liver health, which is now available at the Dr Dangs Lab. Der ELF-Score zeigt eine hohe Korrelation mit den Serum- spiegeln der Aminotransferasen und der Entzündungs-aktivität in der Leber. 29, testing stops; if FIB-4 index value is greater than 1. Introduction: The SAFE (Steatosis-associated Fibrosis Estimator) score is a scoring system to categorize NAFLD patients by their risk of having significant liver fibrosis (stage 2 or higher) and long-term outcome. The utility of the ELF score has been demonstrated primarily in Western countries, but whether it is useful in areas The ELF Score is recommended by AACE guidelines,6 as its measurements have proven valuable for identifying patients with advanced fibrosis (F3 or F4) at risk of progressing to cirrhosis and liver-related events. Metabolic dysfunction-associated steatotic liver disease (MASLD) is a long-lasting liver condition caused by having too much fat in the liver. The ELF score has been validated in diagnosis of advanced fibrosis and predicting complications in patients with established chronic liver disease (3, 4). Enter the required values to calculate the FIB-4 value. We investigated the impact of adding the Enhanced Liver Fibrosis (ELF) score as a second-line test (subsequent to an indeterminate or Sep 22, 2023 · The Enhanced Liver Fibrosis (ELF) test is indicated “as a prognostic marker in conjunction with other laboratory findings and clinical assessments in patients with advanced fibrosis (F3 or F4) due to nonalcoholic steatohepatitis (NASH), to assess the likelihood of progression to cirrhosis and liver-related clinical events. 394 × In (tissue inhibitor of metalloproteinase 1 Feb 10, 2025 · The ELF score is less discriminative in low and moderate fibrosis stages compared to transient elastography, and is more strongly influenced by inflammatory liver injury 5. Jun 7, 2024 · The ELF™ (enhanced liver fibrosis) test produces a single score based on quantitative measurements of three serum markers of extracellular collagen metabolism. ”1 Dec 17, 2023 · This test showed liver stiffness measurement of 12. ELF Sample type: Serum Test name: ELF a. Enhanced liver fibrosis test Condition / Indication: Liver fibrosis marker for investigation of NAFLD. ELF was not an approved test at the time our patient cohort was seen by our office so ELF scores were not available. 5 kPa. FIB-4 1. FIB-4 Index FIB-4 Index What it measures: fibrosis Who should take it: anyone concerned about their liver Where to get it: primary care provider, online calculator The FIB-4 Index is a blood-based diagnostic test that looks at underlying fibrosis that can be used as a measure to help determine NAFLD/NASH status. ”1 NAFLD Fibrosis Score NAFLD Fibrosis Score is a non-invasive tool used to assess the severity of fibrosis in patients with non-alcoholic fatty liver disease. The preferred noninvasive initial test is the FIB-4. Oct 31, 2017 · Liver fibrosis is the main determinant and predictor of the clinical course of nonalcoholic fatty liver disease (NAFLD). A worrying trend is the increasing numbers of cases of cirrhosis due to Assess your liver fibrosis risk with the eLIFT Score Calculator—a user-friendly, non-invasive tool for quick, reliable screening and prompt action today. The performance of the ELF Test has been well-established in the scientific literature, and ease of testing and interpretation support routine clinical use. The enhanced liver fibrosis (ELF) test has been proposed for the non-invasive assessment of advanced fibrosis in patients with non-alcoholic fatty liver disease (NAFLD). 146 ELF = 2. The accuracy of results can be impacted by extremely elevated BMI. The ELF Sep 22, 2023 · The Enhanced Liver Fibrosis (ELF) test is indicated “as a prognostic marker in conjunction with other laboratory findings and clinical assessments in patients with advanced fibrosis (F3 or F4) due to nonalcoholic steatohepatitis (NASH), to assess the likelihood of progression to cirrhosis and liver-related clinical events. The Enhanced Liver Fibrosis (ELF™) Score is also a simple, accurate, non-invasive blood test that calculates a score to measure advanced liver fibrosis. The Enhanced Liver Fibrosis (ELF) score is an ECM marker set consisting of tissue inhibitor of metalloproteinases 1 (TIMP-1), amino-terminal propeptide Clinical Indications Enhanced Liver Fibrosis (ELF) Score - The Enhanced Liver Fibrosis (ELF) score predicts progression to cirrhosis and liver-related events in patients with advanced fibrosis due to NASH. We compared the performance of the enhanced liver fibrosis (ELF) test to the fibrosis-4 index (FIB-4) and NAFLD fibrosis score (NFS), using transient elastography as the reference standard. We would like to show you a description here but the site won’t allow us. 51 suggests advanced liver fibrosis and is an indication for referral to a specialist in hepatology. Webinar: The ELF™ Test as a Universally Available Prognostic Tool for Enhancing NASH Patient Care Hear the clinical perspectives from two industry leaders on how they see the ELF™ Test positively impacting care for NASH patients with advanced liver fibrosis. The ELF Score can be used as a prognostic marker for patients who need urgent specialized intervention. The Enhanced Liver Fibrosis (ELF) panel, is a blood test developed by Siemens Healthineers that measures fibrosis using serum markers. The MELD Score helps to estimate prognosis for patients with end-stage liver disease, and is used to prioritize transplant recipients. Though this test is not commercially available in the United States, ELF is typically used to assess the risk of progression to cirrhosis and liver-related clinical events, most commonly to diagnose advanced If you are at risk of liver disease a FIB-4 or ELF test can help find out how much scarring is in your liver and what should happen next. 3. 278 + 0. The ELF score can be used for estimating the severity of fibrosis, but it is inferior to transient elastography (TE) in estimating liver fibrosis severity 6. NASH FibroSure® Plus test is a noninvasive assessment of liver status in patients with nonalcoholic fatty liver disease (NAFLD). We performed a systematic review to estimate the accuracy of this test against biopsy. Nov 1, 2023 · The Enhanced Liver Fibrosis (ELF™) Test is an effective diagnostic tool used to measure the amount of fibrosis, or scarring, in the liver. There is a need for accurate biomarkers of fibrosis for population screening of alcohol-related and non-alcoholic fatty liver disease (ALD, NAFLD). Aug 1, 2013 · The Enhanced Liver Fibrosis (ELF) score is an ECM marker set consisting of tissue inhibitor of metalloproteinases 1 (TIMP-1), amino-terminal propeptide of type III procollagen (PIIINP) and hyaluronic acid (HA) showing good correlations with fibrosis stages in chronic liver disease. 7–10 ELF is included as a The three direct markers of the ELF Test are complementary and, when combined into an ELF score, provide information that is prognostic for progression to cirrhosis and liver-related events. An ELF Score ≥10. However, there is a lot of interest in these scores, so Mar 7, 2021 · This systematic review assesses the diagnostic accuracy of the enhanced liver fibrosis (ELF) test in cases of advanced fibrosis and cirrhosis due to multiple etiologies in at-risk populations. If the ELF Score is <10. We investigated the impact of adding the Enhanced Liver Fibrosis (ELF) score as a second-line test (subsequent to an indeterminate or high Fibrosis-4 index [FIB-4] and/or non-alcoholic fatty liver disease fibrosis score) to guide referral and prognostication in our multi-aetiology It is used for detecting and staging liver fibrosis, activity and steatosis in people with non-alcoholic fatty liver disease (NAFLD), non-alcoholic steatohepatitis (NASH), hepatitis B and hepatitis C. 5 High risk for advanced liver fibrosis. The ELF test provides a non-invasive approach to evaluate liver health, particularly in chronic liver diseases like hepatitis C and fatty liver disease. You can find the result interpretation and guidelines on the original study that published the score below the form. In this prospective study, we evaluated the use of the ELF score as a predictor of HCC in a population-based cohort of Chinese in Singapore. Background Enhanced liver fibrosis (ELF) score is an accurate, noninvasive test for assessing the severity of liver fibrosis in chronic liver disease, including alcohol‐related liver disease. The innovative aspects are that LIVERFASt may simplify diagnosing and monitoring liver disease and damage. hxxzodc kxxqq wcrdjg xqce rdmi hmnmukf cohlmzs evokej rqxwia xrtrg